Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor

BACKGROUND: Some clinical studies have demonstrated that the proton pump inhibitor (PPI) could decrease clopidogrel platelet response and increase major adverse cardiovascular events (MACE) in white or black subjects. However, that remains to be determined in Chinese patients. In this study, we soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jian-Jun, Chen, Shao-Liang, Tan, Jie, Lin, Ling, Zhao, Ying-Ying, Xu, Hai-Mei, Lin, Song, Zhang, Juan, Fan, Hong-Wei, Xie, Hong-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885647/
https://www.ncbi.nlm.nih.gov/pubmed/24416326
http://dx.doi.org/10.1371/journal.pone.0084985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885647/
https://www.ncbi.nlm.nih.gov/pubmed/24416326
http://dx.doi.org/10.1371/journal.pone.0084985

Ejemplares similares